When analyzed by immunohistochemistry, a minimal or null expression of CD36 was observed in normal tissue samples, whereas 35% of breast tumor samples have high CD36 expression, 46.7% have moderate expression, and only 18.3% low or null expression. This evidence concerns the gene CD36 and breast neoplasm.